A retrospective study analysing efficacy and safety of tolvaptan after pediatric congenital heart disease surgery
Latest Information Update: 27 Sep 2021
At a glance
- Drugs Tolvaptan (Primary)
- Indications Congenital heart defects
- Focus Adverse reactions; Therapeutic Use
- 27 Sep 2021 New trial record